Auger Electron Radioimmunotherapy with 111In-Bn-DTPA-Nimotuzumab Inhibits the Growth of EGFR-Positive Human Breast Cancer Tumours in Mice at Doses that are Non-Toxic to Normal Tissues

被引：0
|
作者：
Chan, C. [1 ]
Fonge, H. [1 ]
Lam, K. [1 ]
Reilly, R. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada
[4] Univ Hlth Network, Joint Dept Med Imaging, Toronto, ON, Canada
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PW070
引用
收藏
页码：S314 / S314
页数：1
相关论文
共 7 条
  • [1] 111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer
    Fasih, Aisha
    Fonge, Humphrey
    Cai, Zhongli
    Leyton, Jeffrey V.
    Tikhomirov, Ilia
    Done, Susan J.
    Reilly, Raymond M.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (01) : 189 - 200
  • [2] 111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer
    Aisha Fasih
    Humphrey Fonge
    Zhongli Cai
    Jeffrey V. Leyton
    Ilia Tikhomirov
    Susan J. Done
    Raymond M. Reilly
    Breast Cancer Research and Treatment, 2012, 135 : 189 - 200
  • [3] MicroSPECT/CT imaging of EGFR-positive tumor xenografts in athymic mice with 111In-Bn-DTPA-nimotuzumab with/without nuclear localization sequence (NLS) peptide modification.
    Fonge, H. A.
    Reilly, R. M.
    Fasih, A.
    Leyton, J.
    Allen, C.
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (04) : 661 - 661
  • [4] Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR
    Chan, Conrad
    Fonge, Humphrey
    Lam, Karen
    Reilly, Raymond M.
    NUCLEAR MEDICINE AND BIOLOGY, 2020, 80-81 : 37 - 44
  • [5] Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of In-111-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer
    Vallis, Katherine A.
    Reilly, Raymond M.
    Scollard, Deborah
    Merante, Pat
    Brade, Anthony
    Velauthapillai, Sobi
    Caldwell, Curtis
    Chan, Ida
    Freeman, Marc
    Lockwood, Gina
    Miller, Naomi A.
    Cornelissen, Bart
    Petronis, Jennifer
    Sabate, Kathryn
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 4 (02): : 181 - 192
  • [6] A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice
    Panosa, Clara
    Fonge, Humphrey
    Ferrer-Batalle, Montserrat
    Menendez, Javier A.
    Massaguer, Anna
    De Llorens, Rafael
    Reilly, Raymond M.
    NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (12) : 931 - 938
  • [7] Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor:: An Auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer
    Reilly, RM
    Chen, P
    Wang, J
    Scollard, D
    Cameron, R
    Vallis, KA
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (06) : 1023 - 1031
1